Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

Danaher Corporation. (1/11/10). "Press Release: Danaher Corporation Offer for Genetix Group plc". Washington, DC.

Organisations Organisation Danaher Corporation (NYSE: DHR)
  Group Danaher (Group)
  Organisation 2 Genetix Group plc (LSE: GTX)
  Today Molecular Devices (New Milton) Limited
  Group Danaher (Group)
Products Product laboratory equipment and instruments
  Product 2 molecular diagnostics
Index term Index term Genetix–Danaher: investment, 200912–201001 acquisition £50m=$82m net of cash acquired recommended cash tender offer 85p/share
     


Danaher Corporation (NYSE:DHR) announced today that it has acquired and received acceptances in respect of approximately 97% of the currently issued shares of Genetix Group plc (GTX:AIM) in relation to its previously announced offer dated December 18, 2009.

Danaher intends to acquire any common shares of Genetix that remain untendered through the compulsory acquisition provisions of the applicable UK companies legislation.

About Danaher

Danaher (NYSE:DHR), based in Washington. D.C., is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by the Danaher Business System, our 50,000 associates serve customers in more than 125 countries and generated $12.7 billion of revenue in 2008. For more information please visit our website: www.danaher.com.

Statements in this document that are not strictly historical, including statements regarding the acquisition of the untendered shares, may constitute forward looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. Information regarding factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher's SEC filings, including Danaher's 2008 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended October 2, 2009. These forward-looking statements speak only as of the date of this release and Danaher does not assume any obligation to update any forward-looking statement.


Please contact:

Matt R. McGrew
Vice President, Investor Relations
Danaher Corporation
2099 Pennsylvania Avenue
Washington, D.C. 20006

Telephone: (202) 828-0850
Fax: (202) 828-0860


   
Record changed: 2016-03-19

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Danaher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top